Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.9550
+0.0224 (2.40%)
Mar 16, 2026, 4:00 PM EDT - Market closed

Standard BioTools Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
85.33174.43106.3497.95130.58
Revenue Growth (YoY)
-51.08%64.03%8.57%-24.99%-5.47%
Cost of Revenue
42.7990.1755.8960.961.21
Gross Profit
42.5484.2650.4537.0569.37
Selling, General & Admin
109.86156.6187.54102.2998.89
Research & Development
25.9962.4125.9537.3837.94
Other Operating Expenses
16.9440.4813.5613.59-
Total Operating Expenses
152.79259.5127.05153.26136.83
Operating Income
-110.25-175.24-76.6-116.21-67.46
Interest Income
9.1820.25.572.237.14
Interest Expense
-0.03-3.32-4.57-4.33-3.82
Other Non-Operating Income (Expense)
4.3920.041.39-74.620.48
Total Non-Operating Income (Expense)
13.5536.922.4-76.723.8
Pretax Income
-96.7-138.31-74.2-192.93-63.66
Provision for Income Taxes
-37.880.570.45-2.83-4.42
Net Income
-149.79-46.01-149.31-380.2-59.24
Earnings From Discontinued Operations
-16.07----
Net Income to Common
-149.79-46.01-149.31-380.2-59.24
Shares Outstanding (Basic)
3823537978137
Shares Outstanding (Diluted)
3823537978137
Shares Change (YoY)
8.03%346.24%1.09%-42.91%90.38%
EPS (Basic)
-0.20-0.52-0.94-2.43-0.64
EPS (Diluted)
-0.20-0.52-0.94-2.43-0.64
Free Cash Flow
-82.65-151.81-46.12-93.2-57.33
Free Cash Flow Per Share
-0.22-0.43-0.58-1.19-0.42
Gross Margin
49.86%48.31%47.44%37.83%53.13%
Operating Margin
-129.20%-100.46%-72.03%-118.64%-51.66%
Profit Margin
-87.77%-79.62%-70.21%-194.08%-45.36%
FCF Margin
-96.86%-87.03%-43.37%-95.15%-43.90%
EBITDA
-99.27-158.38-61.42-101.18-51.89
EBITDA Margin
-116.34%-90.79%-57.76%-103.30%-39.74%
EBIT
-110.25-175.24-76.6-116.21-67.46
EBIT Margin
-129.20%-100.46%-72.03%-118.64%-51.66%
Effective Tax Rate
39.17%-0.41%-0.61%1.47%6.95%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q